PUBLISHER: 360iResearch | PRODUCT CODE: 1598769
PUBLISHER: 360iResearch | PRODUCT CODE: 1598769
Unit Dose Manufacturing Market by Product (Liquid Unit Dose, Solid Unit Dose), Sourcing (In-House, Outsourcing), End-User - Global Forecast 2025-2030
The Unit Dose Manufacturing Market was valued at USD 23.34 billion in 2023, expected to reach USD 27.61 billion in 2024, and is projected to grow at a CAGR of 18.76%, to USD 77.81 billion by 2030.
Unit Dose Manufacturing involves the production of pre-measured, individualized doses of medications and is a vital component within the healthcare and pharmaceutical industries. Its necessity is emphasized by the growing demand for effective medication management, patient safety, and adherence to prescribed therapies, especially in hospitals and long-term care facilities. Applications extend beyond pharmaceuticals into nutraceuticals and over-the-counter medications, leveraging unit doses for precision and safety. End-use sectors include hospitals, home healthcare, and pharmacies. Key factors influencing market growth include increasing chronic disease prevalence, regulatory compliance for medication distribution, and the push for reduced medication errors. The growing trend of home healthcare services and the advancement of automated unit dose packaging technologies present potential opportunities for the market. Notably, technological innovations in smart packaging and automated dispensing systems are areas ripe for investment. However, the market faces limitations such as high initial implementation costs and a complex regulatory landscape that demands rigorous adherence. Moreover, the integration of advanced technologies requires skilled personnel, which can be a challenging factor given the workforce gap in specialized healthcare domains. Innovation and research should focus on developing cost-effective, efficient packaging solutions and integrating digital health technologies that enhance tracking and monitoring of medication adherence. The market's nature is competitive, with companies vying to enhance their technological capabilities and expand their service portfolios. Future growth avenues may include personalized medicine and technologies that facilitate real-time data analytics for better inventory management and patient outcomes. For companies aiming to capitalize on the unit dose manufacturing industry, it is critical to align product offerings with emerging industry trends, focus on regulatory agility, and invest in sustainable packaging solutions that meet both industry standards and consumer expectations.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 23.34 billion |
| Estimated Year [2024] | USD 27.61 billion |
| Forecast Year [2030] | USD 77.81 billion |
| CAGR (%) | 18.76% |
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Unit Dose Manufacturing Market
The Unit Dose Manufacturing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
- Market Drivers
- Increasing adoption of unit doses to reduce medication errors
- Rising awareness of benefits of manufacturing unit doses over repackaging
- Rapid development in the pharmaceutical industry
- Market Restraints
- Fluctuations in the prices of raw materials
- Market Opportunities
- Innovative packaging technologies and delivery solutions
- Adopting continuous manufacturing (CM) for solid-dose drug products
- Market Challenges
- Issues associated with the adoption of manufactured unit doses
Porter's Five Forces: A Strategic Tool for Navigating the Unit Dose Manufacturing Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the Unit Dose Manufacturing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the Unit Dose Manufacturing Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Unit Dose Manufacturing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the Unit Dose Manufacturing Market
A detailed market share analysis in the Unit Dose Manufacturing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the Unit Dose Manufacturing Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Unit Dose Manufacturing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Strategy Analysis & Recommendation: Charting a Path to Success in the Unit Dose Manufacturing Market
A strategic analysis of the Unit Dose Manufacturing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.
Key Company Profiles
The report delves into recent significant developments in the Unit Dose Manufacturing Market, highlighting leading vendors and their innovative profiles. These include Amcor PLC, American Health Packaging, Catalent Inc., Cencora, Inc., Corden Pharma GmbH, Medical Packaging Inc., LLC, Mikart, LLC, Patheon by Thermo Fisher Scientific Inc., The Tapemark Company by LTS Lohmann Therapie-Systeme AG, and Unither Pharmaceuticals SAS.
Market Segmentation & Coverage
This research report categorizes the Unit Dose Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Based on Product, market is studied across Liquid Unit Dose and Solid Unit Dose.
- Based on Sourcing, market is studied across In-House and Outsourcing.
- Based on End-User, market is studied across Hospitals, Independent Pharmacies, and Long Term Care Facility.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
The report offers a comprehensive analysis of the market, covering key focus areas:
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
The report also answers critical questions to aid stakeholders in making informed decisions:
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing adoption of unit doses to reduce medication errors
- 5.1.1.2. Rising awareness of benefits of manufacturing unit doses over repackaging
- 5.1.1.3. Rapid development in the pharmaceutical industry
- 5.1.2. Restraints
- 5.1.2.1. Fluctuations in the prices of raw materials
- 5.1.3. Opportunities
- 5.1.3.1. Innovative packaging technologies and delivery solutions
- 5.1.3.2. Adopting continuous manufacturing (CM) for solid-dose drug products
- 5.1.4. Challenges
- 5.1.4.1. Issues associated with the adoption of manufactured unit doses
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
- 5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental
6. Unit Dose Manufacturing Market, by Product
- 6.1. Introduction
- 6.2. Liquid Unit Dose
- 6.3. Solid Unit Dose
7. Unit Dose Manufacturing Market, by Sourcing
- 7.1. Introduction
- 7.2. In-House
- 7.3. Outsourcing
8. Unit Dose Manufacturing Market, by End-User
- 8.1. Introduction
- 8.2. Hospitals
- 8.3. Independent Pharmacies
- 8.4. Long Term Care Facility
9. Americas Unit Dose Manufacturing Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
10. Asia-Pacific Unit Dose Manufacturing Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
11. Europe, Middle East & Africa Unit Dose Manufacturing Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
12. Competitive Landscape
- 12.1. Market Share Analysis, 2023
- 12.2. FPNV Positioning Matrix, 2023
- 12.3. Competitive Scenario Analysis
- 12.4. Strategy Analysis & Recommendation
Companies Mentioned
- 1. Amcor PLC
- 2. American Health Packaging
- 3. Catalent Inc.
- 4. Cencora, Inc.
- 5. Corden Pharma GmbH
- 6. Medical Packaging Inc., LLC
- 7. Mikart, LLC
- 8. Patheon by Thermo Fisher Scientific Inc.
- 9. The Tapemark Company by LTS Lohmann Therapie-Systeme AG
- 10. Unither Pharmaceuticals SAS
LIST OF FIGURES
- FIGURE 1. UNIT DOSE MANUFACTURING MARKET RESEARCH PROCESS
- FIGURE 2. UNIT DOSE MANUFACTURING MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 5. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 7. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 8. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2023 VS 2030 (%)
- FIGURE 9. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 10. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 11. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 12. AMERICAS UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 13. AMERICAS UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 14. UNITED STATES UNIT DOSE MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 15. UNITED STATES UNIT DOSE MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 16. ASIA-PACIFIC UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 17. ASIA-PACIFIC UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 20. UNIT DOSE MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 21. UNIT DOSE MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
- TABLE 1. UNIT DOSE MANUFACTURING MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 6. UNIT DOSE MANUFACTURING MARKET DYNAMICS
- TABLE 7. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 8. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY LIQUID UNIT DOSE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY SOLID UNIT DOSE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 10. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 11. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 12. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY OUTSOURCING, BY REGION, 2018-2030 (USD MILLION)
- TABLE 13. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 14. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 15. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 16. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY LONG TERM CARE FACILITY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 17. AMERICAS UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 18. AMERICAS UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 19. AMERICAS UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 20. AMERICAS UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 21. ARGENTINA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 22. ARGENTINA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 23. ARGENTINA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 24. BRAZIL UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 25. BRAZIL UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 26. BRAZIL UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 27. CANADA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 28. CANADA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 29. CANADA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 30. MEXICO UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 31. MEXICO UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 32. MEXICO UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 33. UNITED STATES UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 34. UNITED STATES UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 35. UNITED STATES UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 36. UNITED STATES UNIT DOSE MANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 37. ASIA-PACIFIC UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 38. ASIA-PACIFIC UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 39. ASIA-PACIFIC UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 40. ASIA-PACIFIC UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 41. AUSTRALIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 42. AUSTRALIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 43. AUSTRALIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 44. CHINA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 45. CHINA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 46. CHINA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 47. INDIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 48. INDIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 49. INDIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 50. INDONESIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 51. INDONESIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 52. INDONESIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 53. JAPAN UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 54. JAPAN UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 55. JAPAN UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 56. MALAYSIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 57. MALAYSIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 58. MALAYSIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 59. PHILIPPINES UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 60. PHILIPPINES UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 61. PHILIPPINES UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 62. SINGAPORE UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 63. SINGAPORE UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 64. SINGAPORE UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 65. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 66. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 67. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 68. TAIWAN UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 69. TAIWAN UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 70. TAIWAN UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 71. THAILAND UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 72. THAILAND UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 73. THAILAND UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 74. VIETNAM UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 75. VIETNAM UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 76. VIETNAM UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 77. EUROPE, MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 78. EUROPE, MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 79. EUROPE, MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 80. EUROPE, MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 81. DENMARK UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 82. DENMARK UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 83. DENMARK UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 84. EGYPT UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 85. EGYPT UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 86. EGYPT UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 87. FINLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 88. FINLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 89. FINLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 90. FRANCE UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 91. FRANCE UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 92. FRANCE UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 93. GERMANY UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 94. GERMANY UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 95. GERMANY UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 96. ISRAEL UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 97. ISRAEL UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 98. ISRAEL UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 99. ITALY UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 100. ITALY UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 101. ITALY UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 102. NETHERLANDS UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 103. NETHERLANDS UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 104. NETHERLANDS UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 105. NIGERIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 106. NIGERIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 107. NIGERIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 108. NORWAY UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 109. NORWAY UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 110. NORWAY UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 111. POLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 112. POLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 113. POLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 114. QATAR UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 115. QATAR UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 116. QATAR UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 117. RUSSIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 118. RUSSIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 119. RUSSIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 120. SAUDI ARABIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 121. SAUDI ARABIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 122. SAUDI ARABIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 123. SOUTH AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 124. SOUTH AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 125. SOUTH AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 126. SPAIN UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 127. SPAIN UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 128. SPAIN UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 129. SWEDEN UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 130. SWEDEN UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 131. SWEDEN UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 132. SWITZERLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 133. SWITZERLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 134. SWITZERLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 135. TURKEY UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 136. TURKEY UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 137. TURKEY UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 138. UNITED ARAB EMIRATES UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 139. UNITED ARAB EMIRATES UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 140. UNITED ARAB EMIRATES UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 141. UNITED KINGDOM UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 142. UNITED KINGDOM UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
- TABLE 143. UNITED KINGDOM UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 144. UNIT DOSE MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 145. UNIT DOSE MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023
